The plan would seek to improve negotiation within the Medicare program, but not by using the government's clout to negotiate for Medicare as Trump has previously proposed. It would create unspecified incentives for lower list prices of drugs and would lower out-of-pocket spending by patients. ...During his presidential campaign, Trump called for the government to use its clout to negotiate Medicare drug prices, but senior administration officials said he would not call for that change — which is stridently opposed by drug companies. The administration officials did not specify particular policies, but in his budget, Trump proposed changes to Medicare benefits. For example, the budget called for allowing prescription drug plans to have more flexibility to exclude drugs and strike better deals.
Q: Is he for Medicare negotiating drug prices or not?Sean Spicer: He's for it, yes. He wants to make — absolutely. The president's clear — I mean when you look at the cost — not just drug cost. The U.S. government has not done — I mean, you look at what other — frankly, the easier way to look at this is what other countries have done — negotiating costs to keep those down.
Cummings, after sitting down with Trump for roughly an hour in the White House, said the president not only gave his enthusiastic support for Medicare negotiation, he’s also pushing to grant the federal government even broader negotiating powers.“The president was clearly very much aware what was going on. He understood the issue very well,” Cummings told reporters afterward. “And he felt it was important that we address this issue head-on.”